With around a third of the world’s population in lockdown, humanity desperately needs new treatments to turn the tide against COVID-19.
Philip founded Geneva Network in 2015.
His main research interests are the intersection of intellectual property, trade, and health policy. Formerly he was an official at the World Intellectual Property Organization (WIPO) in Geneva, where he worked in its Global Challenges Division on a range of IP and health issues.
Prior to his time with WIPO, Philip worked as director of policy for International Policy Network, a UK-based think tank, as well as holding research positions with the Adam Smith Institute and Reform, both in London. He has also worked as a political risk consultant and a management consultant.
He is a regular columnist in a wide range of international newspapers and has published a number of academic studies. He holds degrees from the London School of Economics and Durham University (UK).
He is also a Senior Fellow at the Institute for Democracy and Economic Affairs, Malaysia.
Separating the cost of biopharmaceutical research and development from the final market price of medicines would misalign incentives, raise bureaucratic costs, and limit innovation.
This week the World Health Organization’s Executive Board meets in Geneva to set the year’s agenda for global health.
The Bangkok Insight covers the latest Geneva Network Report, “Thailand must raise intellectual property protection standards”.
The Bangkok Post, “Improved IP rights crucial to progress” has covered the latest report on…
Laurence Todd, Director of IDEAS Malaysia appeared on Bernama News Channel to discuss the findings…
Geneva Network’s, Philip Stevens appeared on Philippines ABS CBN channel to discuss the importance of…
The Business Inquirer of the Philippines article on the Geneva Network’s intellectual report, “Trade secrets…